Akouos Inc. (AKUS): Price and Financial Metrics
AKUS Price/Volume Stats
| Current price | $13.29 | 52-week high | $13.60 |
| Prev. close | $13.15 | 52-week low | $2.32 |
| Day low | $13.16 | Volume | 1,790,400 |
| Day high | $13.33 | Avg. volume | 344,411 |
| 50-day MA | $10.65 | Dividend yield | N/A |
| 200-day MA | $5.54 | Market Cap | 490.88M |
AKUS Stock Price Chart Interactive Chart >
Akouos Inc. (AKUS) Company Bio
Akouos, Inc. engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna in 2017 and is headquartered in Boston, MA.
AKUS Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 67.17% |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -57.14% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...